{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:53:08Z","timestamp":1761501188911,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3812,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.ymthe.2005.11.017","type":"journal-article","created":{"date-parts":[[2006,1,20]],"date-time":"2006-01-20T08:13:12Z","timestamp":1137744792000},"page":"1016-1026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["In Vivo Effects of Myeloablative Alkylator Therapy on Survival and Differentiation of MGMTP140K-Transduced Human G-CSF-Mobilized Peripheral Blood Cells"],"prefix":"10.1016","volume":"13","author":[{"given":"Shanbao","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Hartwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan J.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth E.","family":"Juliar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Kreklau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafat","family":"Abonour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Scott","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen E.","family":"Pollok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2005.11.017_bib1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.med.56.082103.104546","article-title":"DNA repair defects in stem cell function and aging","volume":"56","author":"Park","year":"2005","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ymthe.2005.11.017_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrc823","article-title":"Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs","volume":"2","author":"Sorrentino","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2005.11.017_bib3","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1200\/JCO.2002.06.110","article-title":"Clinical relevance of MGMT in the treatment of cancer","volume":"20","author":"Gerson","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2005.11.017_bib4","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1200\/JCO.2002.09.084","article-title":"Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma","volume":"20","author":"Quinn","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2005.11.017_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/mthe.2000.0223","article-title":"Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector","volume":"3","author":"Sawai","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.11.017_bib6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1525-0016(03)00205-3","article-title":"Reduction in hematopoietic stem cell numbers with in vivo drug selection can be partially abrogated by HOXB4 gene expression","volume":"8","author":"Sawai","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.11.017_bib7","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1089\/104303403322611728","article-title":"In vivo selection of human hematopoietic cells in a xenograft model using combined pharmacologic and genetic manipulations","volume":"14","author":"Pollok","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2005.11.017_bib8","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ymthe.2004.07.019","article-title":"Enhanced in vivo selection of bone marrow cells by retroviral-mediated coexpression of mutant O6-methylguanine-DNA-methyltransferase and HOXB4","volume":"10","author":"Milsom","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.11.017_bib9","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1172\/JCI200317922","article-title":"In vivo selection of MGMT(P140K) lentivirus-transduced human NOD\/SCID repopulating cells without pretransplant irradiation conditioning","volume":"112","author":"Zielske","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2005.11.017_bib10","first-page":"163","article-title":"Simultaneous protection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitization of tumor cells using O6-benzylguanine and temozolomide","volume":"5","author":"Reese","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2005.11.017_bib11","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI200318782","article-title":"Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model","volume":"112","author":"Neff","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2005.11.017_bib12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood-2004-08-3169","article-title":"Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy","volume":"105","author":"Neff","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.017_bib13","first-page":"1321","article-title":"Hematopoietic expression of O(6)-methylguanine DNA methyltransferase-P140K allows intensive treatment of human glioma xenografts with combination O(6)-benzylguanine and 1,3-bis-(2-chloroethyl)-1-nitrosourea","volume":"2","author":"Kreklau","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ymthe.2005.11.017_bib14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1182\/blood-2003-03-0677","article-title":"Successful treatment of murine {beta}-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells","volume":"102","author":"Persons","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.017_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymthe.2003.11.003","article-title":"In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication","volume":"9","author":"Davis","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.11.017_bib16","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1182\/blood.V95.10.3078","article-title":"Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection","volume":"95","author":"Davis","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.017_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000061986","article-title":"O6-benzylguanine-resistant mutant MGMT genes improve hematopoietic cell tolerance to alkylating agents","volume":"36","author":"Davis","year":"1999","journal-title":"Prog. Exp. Tumor Res."},{"key":"10.1016\/j.ymthe.2005.11.017_bib18","first-page":"5093","article-title":"Selection for G156A O6-methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea","volume":"57","author":"Davis","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2005.11.017_bib19","first-page":"5187","article-title":"Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells","volume":"60","author":"Ragg","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2005.11.017_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.cgt.7700490","article-title":"Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells","volume":"9","author":"Jansen","year":"2002","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ymthe.2005.11.017_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.exphem.2004.05.022","article-title":"Nuclear-localizing O6-benzylguanine-resistant GFP-MGMT fusion protein as a novel in vivo selection marker","volume":"32","author":"Choi","year":"2004","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ymthe.2005.11.017_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymthe.2003.11.011","article-title":"Efficient gene transfer to hematopoietic repopulating cells using concentrated RD114-pseudotype vectors produced by human packaging cells","volume":"9","author":"Neff","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.11.017_bib23","first-page":"5123","article-title":"Metabolism of O6-benzylguanine, an inactivator of O6-alkylguanine-DNA alkyltransferase","volume":"54","author":"Dolan","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2005.11.017_bib24","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1073\/pnas.87.14.5368","article-title":"Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents","volume":"87","author":"Dolan","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2005.11.017_bib25","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1089\/10430349950018418","article-title":"DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts","volume":"10","author":"Koc","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2005.11.017_bib26","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0022-3565(24)35236-X","article-title":"Prolonged inhibition of O(6)-methylguanine DNA methyltransferase in human tumor cells by O(6)-benzylguanine in vitro and in vivo","volume":"291","author":"Kreklau","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymthe.2005.11.017_bib27","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-3565(24)29566-5","article-title":"Comparison of single- versus double-bolus treatments of O(6)-benzylguanine for depletion of O(6)-methylguanine DNA methyltransferase (MGMT) activity in vivo: development of a novel fluorometric oligonucleotide assay for measurement of MGMT activity","volume":"297","author":"Kreklau","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymthe.2005.11.017_bib28","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V98.10.2900","article-title":"Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?","volume":"98","author":"Korbling","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.017_bib29","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2002-01-0048","article-title":"A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies","volume":"100","author":"Couban","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.017_bib30","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1089\/10430340152677430","article-title":"Differential transduction efficiency of SCID-repopulating cells derived from umbilical cord blood and granulocyte colony-stimulating factor-mobilized peripheral blood","volume":"12","author":"Pollok","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2005.11.017_bib31","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1093\/nar\/29.12.2558","volume":"29","author":"Kreklau","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2005.11.017_bib32","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1182\/blood.V96.6.2100","article-title":"Similar repopulating capacity of mitotically active and resting umbilical cord blood CD34(+) cells in NOD\/SCID mice","volume":"96","author":"Wilpshaar","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.017_bib33","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood.V92.8.2641","article-title":"Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic\/severe combined immune-deficient mice","volume":"92","author":"Gothot","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.017_bib34","doi-asserted-by":"crossref","first-page":"S385","DOI":"10.1016\/j.ymthe.2004.06.944","article-title":"Preliminary results of a phase I trial using retroviral gene transfer of G156A MGMT to protect hematopoiesis during BG and BCNU therapy of advanced malignancies","volume":"9","author":"Reese","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.11.017_bib35","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1128\/jvi.65.5.2220-2224.1991","article-title":"Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus","volume":"65","author":"Miller","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.11.017_bib36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1172\/JCI12593","article-title":"Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates","volume":"108","author":"Takatoku","year":"2001","journal-title":"J. Clin. Invest."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001605017132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001605017132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:49:37Z","timestamp":1761500977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001605017132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S1525001605017132"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2005.11.017","relation":{},"ISSN":["1525-0016"],"issn-type":[{"type":"print","value":"1525-0016"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vivo Effects of Myeloablative Alkylator Therapy on Survival and Differentiation of MGMTP140K-Transduced Human G-CSF-Mobilized Peripheral Blood Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2005.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}